Mengqi Luo

<scp>TRIM26</scp> inhibits hepatitis B virus replication by promoting <scp>HBx</scp> degradation and <i>TRIM26</i> genetic polymorphism predicts <scp>PegIFNα</scp> treatment response of <scp>HBeAg‐positive</scp> chronic hepatitis B Patients

Mengqi Luo, Jia Hou, Haoming Mai et al. · Alimentary Pharmacology & Therapeutics · 2022 · 20 citations

Life Sciences, Genetics, Molecular Biology +15

Implications of Stemness Features in 1059 Hepatocellular Carcinoma Patients from Five Cohorts: Prognosis, Treatment Response, and Identification of Potential Compounds

Haoming Mai, Haisheng Xie, Mengqi Luo et al. · Cancers · 2022 · 13 citations · Full text

Medicine, Cancer Biology, Oncology +17

A functional variant of<i>CD40</i>modulates clearance of hepatitis B virus in hepatocytes via regulation of the ANXA2/CD40/BST2 axis

Jiaxuan Chen, Haitao Chen, Haoming Mai et al. · Human Molecular Genetics · 2022 · 10 citations · Full text

Life Sciences, Genetics, Molecular Biology +14

<i>CXCL13</i> variant predicts pegylated‐interferon α treatment response in HBeAg‐positive chronic hepatitis B patients

Mengqi Luo, Lingyan Zhang, Chou Yang et al. · Journal of Medical Virology · 2023 · 10 citations · Full text

Medicine, Molecular Genetics, Pharmacology +17